医学
美罗华
内科学
胃肠病学
幽门螺杆菌
耐火材料(行星科学)
淋巴瘤
马尔特淋巴瘤
边缘区B细胞淋巴瘤
免疫学
边缘地带
B细胞
抗体
物理
天体生物学
作者
Giovanni Martinelli,Daniele Laszlò,Andrés J.M. Ferreri,Giancarlo Pruneri,Maurilio Ponzoni,Annarita Conconi,C. Crosta,E Pedrinis,Francesco Bertoni,Liliana Calabrese,Emanuele Zucca
标识
DOI:10.1200/jco.2005.08.128
摘要
Our experience seems to confirm the clinical activity of rituximab in gastric MALT NHL patients resistant/refractory to antibiotics treatment or not presenting with clinical evidence of Helicobacter pylori infection. The t(11; 18)(q21; q21) translocation seems not to be a predictive marker to response or to subsequent relapse.
科研通智能强力驱动
Strongly Powered by AbleSci AI